Prof. Dr. Markus Metzler



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Complications at Diagnosis of Pediatric Chronic Myeloid Leukemia in Chronic Phase (2025) Roy Moulik N, Athale U, Metzler M, Millot F, Suttorp M Journal article, Review article A high proportion of germline variants in pediatric chronic myeloid leukemia (2024) Krumbholz M, Dolnik A, Sträng E, Ghete T, Skambraks S, Hutter S, Simonis A, et al. Journal article Effectiveness of structured, multidisciplinary long-term care for pediatric cancer survivors: protocol of the multicenter, randomized-controlled AELKI study (2024) Schmidt H, Baust K, Calaminus G, Hohls L, Tetzner K, Griech N, Haugke H, et al. Journal article Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients (2024) Hovorkova L, Winkowska L, Skorepova J, Krumbholz M, Benesova A, Polivkova V, Alten J, et al. Journal article Hodgkin lymphoma: hypodense lesions in mediastinal masses (2024) Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A, Cepelova M, Ceppi F, et al. Journal article Impact of age on safety of Busulfan-Melphalan followed by autologous hematopoietic stem-cell transplantation versus standard chemotherapy in the patients of the EURO-E.W.I.N.G. 99 and Ewing 2008 clinical trials (2024) Choderlos de Laclos X, Risbourg S, Marec-Bérard P, Cécile Le Deley M, Tabone MD, Bertucci F, Gaspar N, et al. Journal article Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohort (2024) Stiehler S, Sembill S, Schleicher O, Marx M, Rauh M, Krumbholz M, Karow A, et al. Journal article Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial (2024) Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, et al. Journal article An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasia (2024) Tang M, Antić Ž, Fardzadeh P, Pietzsch S, Schröder C, Eberhardt A, van Bömmel A, et al. Journal article Osteosarcomas in retinoblastoma-survivors. A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS) (2024) Bielack SS, Baumhoer D, Hecker-Nolting S, Hettmer S, Kager L, Ketteler P, Kevric M, et al. Journal article